APCCC Diagnostics 2025 – APCCC

The diagnostic abilities for assessing prostate cancer patients have significantly evolved in the last years. Ranging from advanced imaging modalities for detection, new innovative liquid and tissue based biomarkers as well as the recent introduction of PSMA PET imaging have significantly advanced the field, challenging some of the old grounds of truth. The introduction of the Advanced Prostate Cancer Consensus Conference (APCCC) in 2015 represents a milestone of establishing clinical consensus in the

Read the full article here

Source: apccc.org

Categories: Oncologists1, General Medicine News

Tags: APCCCDiagnostics25

Tweets with this article

OncoAlert

Dear Colleagues A warm invitation to JOIN US at #APCCCDiagnostics25 A HYBRID Meeting (In Person & Live) in Lugano Switzerland February 27-28, 2025 REGISTER: https://t.co/liXpdhy66c Enjoy Early Bird Registration, NOW OPEN ONLINE REGISTRATION FOR LMIC's FREE‼️ OncoAlert 🚨Will… https://t.co/UyKObpyq07 https://t.co/pPhDUcVQN5

Middle East crisis live: Israel orders closure of one of last functioning hospitals in northern Gaza

Head of Kamal Adwan hospital says it is ‘next to impossible’ to obey shut down order due to lack of ambulances to evacuate patients

Simon Chowdhury December 23, 2024

Prophylactic Tocilizumab Reduces Toxicity, Boosts Efficacy in Immune Checkpoint Inhibitor–Treated Melanoma

Matthew Hadfield, DO, discusses findings from a phase 2 study that used tocilizumab to reduce toxicities with immune checkpoint inhibitors in melanoma.

OncLive.com December 23, 2024

How to make transplanted stem cells feel at home

In this issue of Blood, Verkamp and colleagues1 present a retrospective analysis of the emapalumab (anti-interferon gamma [IFN-γ] monoclonal antibody) use

Blood Journal December 23, 2024

Remote Symptom Monitoring of Patients With Advanced Lung Cancer (The ProWide Study): A Randomized Controlled Trial | JCO Oncology Practice

PURPOSERemote symptom monitoring of patients with cancer has previously shown potential for improving clinical outcomes. This study aimed to evaluate the effects of remote symptom…

J Oncology Practice December 23, 2024

Myasthenia Gravis Research Highlights: AAN 2024

Nicholas Silvestri, MD, of the Univ of Buffalo, provides an overview of the latest myasthenia gravis clinical research presented at AAN 2024.

CheckRare December 23, 2024

Childhood Cancer Data Initiative (CCDI)

The Childhood Cancer Data Initiative addresses the critical need to collect, analyze, and share data to speed up progress against childhood cancer.  

National Cancer Institute December 23, 2024

Highlights of ASH in the Mediterranean, Middle East, and North Africa

Join the world’s leading hematology experts at Highlights of ASH in the Mediterranean, Middle East, and North Africa, a two-day program that highlights the most…

ASH December 23, 2024

Osteosarcoma Spheroid Models Provide Key Tool for Preclinical Drug Development

R. Lor Randall, MD, FACS, discusses the construction and preclinical utility of spheroid models for drug development in osteosarcoma.

OncLive.com December 23, 2024

Become a Member Today

The American Society for Transplantation and Cellular Therapy is an international professional membership association of more than 3,900 physicians, investigators and other health care professionals…

ASTCT December 23, 2024

Coffee and tea consumption and the risk of head and neck cancer: An updated pooled analysis in the International Head and Neck Cancer Epidemiology Consortium

A pooled analysis of 9548 HNC cases and 15,783 controls from the International Head and Neck Cancer Epidemiology consortium was conducted to assess the association…

OncoAlert December 23, 2024

Related Articles